Skip to main content

3 Result(s)

within Judith A. Aberg Remove this filter Pharmacology/Toxicology Remove this filter

and

  1. Article

    Open Access

    Toward Safer Opioid Prescribing in HIV care (TOWER): a mixed-methods, cluster-randomized trial

    The 2016 U.S. Centers for Disease Control Opioid Prescribing Guideline (CDC Guideline) is currently being revised amid concern that it may be harmful to people with chronic pain on long-term opioid therapy (CP...

    Gabriela Cedillo, Mary Catherine George… in Addiction Science & Clinical Practice (2022)

    Download PDF (1402 KB) View Article

  2. No Access

    Article

    Soluble Levels of Receptor for Advanced Glycation Endproducts (RAGE) and Progression of Atherosclerosis in Individuals Infected with Human Immunodeficiency Virus: ACTG NWCS 332

    Identification of biomarkers and/or mediators of cardiovascular disease (CVD) associated with HIV infection would be of diagnostic and therapeutic value. As soluble receptor for advanced glycation endproducts ...

    Ann Danoff, Michelle A. Kendall, Judith S. Currier, Theodoros Kelesidis… in Inflammation (2016)

  3. No Access

    Article

    Neuropsychiatric Complications of Antiretroviral Therapy

    Neuropsychiatric adverse effects related to potent antiretroviral therapy are among the complications that can lead to poor adherence, treatment interruptions, or change of antiretroviral therapy regimens. For...

    Dr Michelle S. Cespedes, Judith A. Aberg in Drug Safety (2006)